Standard Biotools (LAB) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Standard Biotools (LAB) over the last 17 years, with Q3 2025 value amounting to -$194.9 million.
- Standard Biotools' Enterprise Value rose 4698.26% to -$194.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$194.9 million, marking a year-over-year increase of 4698.26%. This contributed to the annual value of -$292.9 million for FY2024, which is 15315.41% down from last year.
- Per Standard Biotools' latest filing, its Enterprise Value stood at -$194.9 million for Q3 2025, which was up 4698.26% from -$237.1 million recorded in Q2 2025.
- Standard Biotools' Enterprise Value's 5-year high stood at -$29.5 million during Q4 2021, with a 5-year trough of -$463.6 million in Q1 2024.
- In the last 5 years, Standard Biotools' Enterprise Value had a median value of -$166.8 million in 2022 and averaged -$183.8 million.
- In the last 5 years, Standard Biotools' Enterprise Value surged by 5866.28% in 2021 and then plummeted by 56572.67% in 2022.
- Over the past 5 years, Standard Biotools' Enterprise Value (Quarter) stood at -$29.5 million in 2021, then crashed by 466.05% to -$166.8 million in 2022, then skyrocketed by 30.64% to -$115.7 million in 2023, then plummeted by 153.15% to -$292.9 million in 2024, then surged by 33.45% to -$194.9 million in 2025.
- Its Enterprise Value was -$194.9 million in Q3 2025, compared to -$237.1 million in Q2 2025 and -$258.1 million in Q1 2025.